Christoph Wyen

Koeln, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Characteristics of late HIV diagnosis in Germany in 2019 and 2020 - A regional analysis.

Characteristics of late HIV diagnosis in Germany in 2019 and 2020 - A regional analysis.

Journal: Infection

Published: July 03, 2026

The outpatient economic burden of respiratory syncytial virus infection in adults aged ≥ 60 years in Germany: results from the BUCOSS study.

The outpatient economic burden of respiratory syncytial virus infection in adults aged ≥ 60 years in Germany: results from the BUCOSS study.

Journal: Respiratory research

Published: April 28, 2026

Adherence to Hepatocellular Carcinoma Surveillance Guidelines Among People with HIV and Chronic HBV Infection.

Adherence to Hepatocellular Carcinoma Surveillance Guidelines Among People with HIV and Chronic HBV Infection.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: January 14, 2026

Cabotegravir+rilpivirine long-acting every 2 months in a real-world setting: 24-month outcomes in people with HIV-1.

Cabotegravir+rilpivirine long-acting every 2 months in a real-world setting: 24-month outcomes in people with HIV-1.

Journal: AIDS (London, England)

Published: October 02, 2025

Cabotegravir+rilpivirine long-acting every 2 months in a real-world setting: 24-month outcomes in people with HIV-1.

Cabotegravir+rilpivirine long-acting every 2 months in a real-world setting: 24-month outcomes in people with HIV-1.

Journal: AIDS (London, England)

Published: October 02, 2025

Hepatitis D virus infection prevalence in persons with human immunodeficiency virus and hepatitis B virus coinfection in Germany.

Hepatitis D virus infection prevalence in persons with human immunodeficiency virus and hepatitis B virus coinfection in Germany.

Journal: Infection

Published: September 14, 2025

Both Smallpox and Mpox Vaccine Reduce Mpox Disease Severity and Symptoms.

Both Smallpox and Mpox Vaccine Reduce Mpox Disease Severity and Symptoms.

Journal: Open forum infectious diseases

Published: August 19, 2025

The effect of antibiotic therapy on clinical outcome in patients hospitalized with moderate COVID-19 disease: a prospective multi-center cohort study.

The effect of antibiotic therapy on clinical outcome in patients hospitalized with moderate COVID-19 disease: a prospective multi-center cohort study.

Journal: Infection

Published: March 04, 2025

Effectiveness of switching to doravirine-based antiretroviral therapy: A real-world study in Germany.

Effectiveness of switching to doravirine-based antiretroviral therapy: A real-world study in Germany.

Journal: HIV medicine

Published: November 04, 2024

Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study.

Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study.

Journal: The Lancet. Infectious diseases

Published: October 03, 2024

Discrimination of the Veterans Aging Cohort Study Index 2.0 for Predicting Cause-specific Mortality Among Persons With HIV in Europe and North America.

Discrimination of the Veterans Aging Cohort Study Index 2.0 for Predicting Cause-specific Mortality Among Persons With HIV in Europe and North America.

Journal: Open forum infectious diseases

Published: April 15, 2024

Stage-adapted treatment of HIV-associated Hodgkin lymphoma: Long-term results of a prospective, multicenter study.

Stage-adapted treatment of HIV-associated Hodgkin lymphoma: Long-term results of a prospective, multicenter study.

Journal: HemaSphere

Published: January 26, 2024

Showing 1-12 of 71

Last Updated: 09/26/2026